12 results on '"Balcells M"'
Search Results
2. Haemorrhagic pure motor stroke
- Author
-
Arboix, A., primary, García-Eroles, L., additional, Massons, J., additional, Oliveres, M., additional, and Balcells, M., additional
- Published
- 2007
- Full Text
- View/download PDF
3. Influence of surfactant molecules as air‐entraining agent for bone cement macroporosity
- Author
-
Sarda, S., primary, Nilsson, M., additional, Balcells, M., additional, and Fernández, E., additional
- Published
- 2003
- Full Text
- View/download PDF
4. Kinetic study of citric acid influence on calcium phosphate bone cements as water-reducing agent
- Author
-
Sarda, S., primary, Fernández, E., additional, Nilsson, M., additional, Balcells, M., additional, and Planell, J. A., additional
- Published
- 2002
- Full Text
- View/download PDF
5. Quantitative Beschreibung von Proteinadsorptionsprozessen an Polymeroberflächen mittels ELISA
- Author
-
Balcells, M., primary, Klee, D., additional, and Höcker, H., additional
- Published
- 1999
- Full Text
- View/download PDF
6. ChemInform Abstract: Cycloaddition Intermediates: Zwitterions or Diradicals?
- Author
-
BALCELLS, M., primary, DURAN, M., additional, LLEDOS, A., additional, and BERTRAN, J., additional
- Published
- 1987
- Full Text
- View/download PDF
7. A simplified techno-economic model for the molecular pharming of antibodies.
- Author
-
Mir-Artigues P, Twyman RM, Alvarez D, Cerda Bennasser P, Balcells M, Christou P, and Capell T
- Subjects
- Animals, Antibodies, Monoclonal chemistry, Antibodies, Monoclonal genetics, CHO Cells, Cricetulus, Recombinant Proteins biosynthesis, Recombinant Proteins chemistry, Recombinant Proteins genetics, Recombinant Proteins isolation & purification, Antibodies, Monoclonal biosynthesis, Antibodies, Monoclonal isolation & purification, Biotechnology
- Abstract
By the end of 2017, the Food and Drug Administration had approved a total of 77 therapeutic monoclonal antibodies (mAbs), most of which are still manufactured today. Furthermore, global sales of mAbs topped $90 billion in 2017 and are projected to reach $125 billion by 2020. The mAbs approved for human therapy are mostly produced using Chinese hamster ovary (CHO) cells, which require expensive infrastructure for production and purification. Molecular pharming in plants is an alternative approach with the benefits of lower costs, greater scalability, and intrinsic safety. For some platforms, the production cycle is also much quicker. But do these advantages really stack up in economic terms? Earlier techno-economic evaluations have focused on specific platforms or processes and have used different methods, making direct comparisons challenging and the overall benefits of molecular pharming difficult to gauge. Here, we present a simplified techno-economic model for the manufacturing of mAbs, which can be applied to any production platform by focusing on the most important factors that determine the efficiency and cost of bulk drug manufacturing. This model develops economic concepts to identify variables that can be used to achieve cost savings by simultaneously modeling the dynamic costs of upstream production at different scales and the corresponding downstream processing costs for different manufacturing modes (sequential, serial, and continuous). The use of simplified models will help to achieve meaningful comparisons between diverse manufacturing technologies., (© 2019 Wiley Periodicals, Inc.)
- Published
- 2019
- Full Text
- View/download PDF
8. Comprehensive Two-dimensional Gas Chromatography Time-of-flight Mass Spectrometry to Assess the Presence of α,α-Trehalose and Other Disaccharides in Apple and Peach.
- Author
-
Marsol-Vall A, Balcells M, Eras J, and Canela-Garayoa R
- Subjects
- Disaccharides chemistry, Food Analysis instrumentation, Food Analysis methods, Fruit chemistry, Gas Chromatography-Mass Spectrometry instrumentation, Gas Chromatography-Mass Spectrometry standards, Limit of Detection, Disaccharides analysis, Gas Chromatography-Mass Spectrometry methods, Malus chemistry, Prunus persica chemistry, Trehalose analysis
- Abstract
Introduction: Carbohydrates are important constituents in fruits. Among the carbohydrates, disaccharides have rarely been studied in apple and peach. Indeed, the abiotic stress biomarker and preservation agent α,α-trehalose is a disaccharide., Objectives: To establish a comprehensive method based on two-dimensional gas chromatography combined with time-of-flight MS detection (GC × GC-ToF/MS) to analyse the disaccharide composition of apple and peach., Methods: The sample preparation was based on aqueous-methanolic extraction of the analytes, followed by oxime formation and trimethylsilylation of the disaccharides. First, three columns were tested with standards on the one-dimensional system. Next, to perform the sample analysis using GC × GC-MS (which offers significant advantages over conventional GC because it allows higher separation efficiencies), various column configurations were assessed on the two-dimensional system to obtain enhanced separation and low detection limits. The column sets tested included non-polar/semi-polar, semi-polar/polar and polar/non-polar., Results: Using the method that proved to be more efficient, namely the method developed with the semi-polar/non-polar configuration, ten disaccharides were identified, based on analytical standards, retention index and mass spectra. These compounds were quantified in several varieties of apple and peach fruit using the developed GC × GC method and linear curve calibration, resulting in substantial differences among the fruits. However, cultivars within the fruits exhibited no significant differences., Conclusion: The proposed method allowed for the identification and quantification of several disaccharides in apple and peach, including the biomarker α,α-trehalose., (Copyright © 2015 John Wiley & Sons, Ltd.)
- Published
- 2015
- Full Text
- View/download PDF
9. Toxicity of allyl esters in insect cell lines and in Spodoptera littoralis larvae.
- Author
-
Giner M, Avilla J, Balcells M, Caccia S, and Smagghe G
- Subjects
- Animals, Cell Line, Coleoptera growth & development, Drosophila melanogaster growth & development, Larva drug effects, Larva growth & development, Moths growth & development, Species Specificity, Spodoptera drug effects, Spodoptera growth & development, Tetrazolium Salts chemistry, Thiazoles chemistry, Trypan Blue chemistry, Coleoptera drug effects, Drosophila melanogaster drug effects, Esters pharmacology, Insecticides pharmacology, Moths drug effects
- Abstract
We investigated the effects of five allyl esters, two aromatic (allyl cinnamate and allyl 2-furoate) and three aliphatic (allyl hexanoate, allyl heptanoate, and allyl octanoate) in established insect cell lines derived from different species and tissues. We studied embryonic cells of the fruit fly Drosophila melanogaster (S2) (Diptera) and the beet armyworm Spodoptera exigua (Se4) (Lepidoptera), fat body cells of the Colorado potato beetle Leptinotarsa decemlineata (CPB) (Coleoptera), ovarian cells of the silkmoth Bombyx mori (Bm5), and midgut cells of the spruce budworm Choristoneura fumiferana (CF203) (Lepidoptera). Cytotoxicity was determined with use of MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide] and trypan blue. In addition, we tested the entomotoxic action of allyl cinnamate against the cotton leafworm Spodoptera littoralis .The median (50%) cytotoxic concentrations (EC₅₀s) of the five allyl esters in the MTT bioassays ranged between 0.25 and 27 mM with significant differences among allyl esters (P = 0.0012), cell lines (P < 0.0001), and the allyl ester-cell line interaction (P < 0.0001). Allyl cinnamate was the most active product, and CF203 the most sensitive cell line. In the trypan blue bioassays, cytotoxicity was produced rapidly and followed the same trend observed in the MTT bioassay. In first instars of S. littoralis, allyl cinnamate killed all larvae at 0.25% in the diet after 1 day, while this happened in third instars after 5 days. The LC₅₀ in first instars was 0.08%. In addition, larval weight gain was reduced (P < 0.05) after 1 day of feeding on diet with 0.05%. In conclusion, the data provide evidence of the significant but differential cytotoxicity among allyl esters in insect cells of different species and tissues. Midgut cells show high sensitivity, indicating the insect midgut as a primary target tissue. Allyl cinnamate caused rapid toxic effects in S. littoralis larvae at low concentrations, suggesting further potential for use in pest control., (© 2011 Wiley Periodicals, Inc.)
- Published
- 2012
- Full Text
- View/download PDF
10. Combining regio- and enantioselectivity of lipases for the preparation of (R)-4-chloro-2-butanol.
- Author
-
Méndez JJ, Oromi M, Cervero M, Balcells M, Torres M, and Canela R
- Subjects
- Aspergillus flavus metabolism, Butanols chemistry, Rhizopus metabolism, Stereoisomerism, Structure-Activity Relationship, Temperature, Butanols metabolism, Lipase physiology
- Abstract
Preparation of 98% ee (R)-4-chloro-2-butanol was carried out by the enzymatic hydrolysis of chlorohydrin esters, using fungal resting cells and commercial enzymes. Hydrolyzes were carried out using lipases from Candida antarctica (Novozym 435), C. rugosa, Rhizomucor miehei (Lipozyme IM), Burkolia cepacia, and resting cells of Rhizopus oryzae and Aspergillus flavus. The influence of the enzyme, the solvent, the temperature, and the alkyl chain length on the selectivity of hydrolyzes of isomeric mixtures of chlorohydrin esters is described. Regioselectivity was higher than 95% for some of the tested lipases. Novozym 435 allowed preparation of the (R)-4-chloro-2-butanol after 15 min of reaction at 30-40 degrees C., ((c) 2006 Wiley-Liss, Inc.)
- Published
- 2007
- Full Text
- View/download PDF
11. Predicting spontaneous early neurological recovery after acute ischemic stroke.
- Author
-
Arboix A, García-Eroles L, Comes E, Oliveres M, Balcells M, Pacheco G, and Targa C
- Subjects
- Acute Disease, Aged, Aged, 80 and over, Brain Ischemia classification, Brain Ischemia diagnosis, Cohort Studies, Female, Hospitals, Humans, Incidence, Male, Middle Aged, Multivariate Analysis, Predictive Value of Tests, Prognosis, Prospective Studies, Reproducibility of Results, Risk Factors, Sensitivity and Specificity, Treatment Outcome, Brain Ischemia complications, Recovery of Function physiology, Stroke complications
- Abstract
We assessed predictors of spontaneous early neurological recovery after acute ischemic stroke by means of multivariate analysis in a cohort of 1,473 consecutive patients treated at one academic center. At hospital discharge, spontaneous neurological improvement or good outcome was defined as grades 0-2 of the Rankin scale, and poor outcome (no improvement or in-hospital death) as grades 3-5. Spontaneous recovery of neurological deficit at the time of discharge from the hospital was observed in 16% of patients with cerebral infarction (n = 238). Dysarthria-clumsy hand syndrome improved in 44% of patients and was the only variable significantly associated with in-hospital functional recovery in three logistic regression models that in addition to lacunar syndromes, included demographic variables, cardiovascular risk factors, and clinical variables [odds ratio (OR) 2.56], neuroimaging findings (OR 2.48), and outcome data (OR 2.39), respectively. Clinical factors related to severity of infarction available at stroke onset have a predominant influence upon in-hospital outcome and may help clinicians to assess prognosis more accurately. Our work gives a contribution into prognostic factors after acute ischemic stroke. With regard to patterns of stroke, dysarthria-clumsy hand syndrome was a significant predictor of spontaneous in-hospital recovery in ischemic stroke patients.
- Published
- 2003
- Full Text
- View/download PDF
12. Phase II study of irinotecan as first-line chemotherapy for patients with advanced colorectal carcinoma.
- Author
-
Fírvida JL, Irigoyen A, Vázquez-Estévez S, Díz P, Constenla M, Casal-Rubio J, Valladares-Ayerbes M, Castellanos J, Rodríguez R, and Balcells M
- Subjects
- Adult, Aged, Colorectal Neoplasms pathology, Humans, Irinotecan, Middle Aged, Neoplasm Metastasis, Survival Analysis, Antineoplastic Agents, Phytogenic therapeutic use, Camptothecin analogs & derivatives, Camptothecin therapeutic use, Colorectal Neoplasms drug therapy
- Abstract
Background: The objective of this multicenter, open-labeled, Phase II study performed in Spain was to assess the efficacy and safety of irinotecan (CPT-11) as first-line chemotherapy for patients suffering from advanced colorectal carcinoma (CRC)., Methods: Patients with histologically proven CRC and at least one bidimensionally measurable lesion, ages 18-70 years, with a performance status < or = 2, normal analytical values, and no prior chemotherapy or only adjuvant chemotherapy completed before study entry were selected. The treatment schedule was CPT-11 350 mg/m(2) intravenously administered once every 3 weeks. Both tumor response and toxicity were assessed using the World Health Organization and National Cancer Institute common toxicity criteria. Changes in performance status, weight, and symptoms also were measured., Results: Sixty-five patients (44 chemotherapy-naïve patients and 21 patients who completed prior adjuvant treatment) were enrolled. Of these, 24.7% of patients responded to the treatment, and 41.5% of patients had stable disease. Patients who had not received prior adjuvant chemotherapy had a lower rate of progression on therapy (27.3%) compared with those who had received prior adjuvant chemotherapy (42.9%). The median survival was 19.9 months (range, 0.3-29.3 months). No significant differences were found in the median survival between chemotherapy-naïve patients and patients who had received previous chemotherapy. Grade 3-4 diarrhea and neutropenia were the most frequent severe toxic events, which were observed in 23.1% and 30.8% of patients and in 5.9% and 10.9% of the cycles, respectively., Conclusions: The current antitumor efficacy results show that 350 mg/m(2) of CPT-11 administered every 3 weeks is an active and feasible first-line chemotherapy regimen for patients with CRC. Finally, the overall safety data confirmed that CPT-11 is a well tolerated treatment., (Copyright 2001 American Cancer Society.)
- Published
- 2001
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.